Payne A H, Sha L L
Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor 48109-0278.
Endocrinology. 1991 Sep;129(3):1429-35. doi: 10.1210/endo-129-3-1429.
The regulation of mRNA levels for delta 5-3 beta-hydroxysteroid dehydrogenase/delta 5----delta 4-isomerase (3 beta HSD), 17 alpha-hydroxylase/C17-20 lyase cytochrome P450 (P450(17 alpha] and cholesterol side-chain cleavage cytochrome P450 (P450scc) was studied in primary cultures of mouse Leydig cells. Treatment of Leydig cells with 8-bromo-cAMP (cAMP) was essential for expression of P450(17 alpha) mRNA, but not for 3 beta HSD. Treatment with cAMP caused a decrease in basal levels of 3 beta HSD mRNA. The addition of aminoglutethimide (AG), an inhibitor of cholesterol metabolism, to the cAMP-treated cultures resulted in increased expression of both 3 beta HSD and P450(17 alpha) mRNA levels. The addition of testosterone or the androgen agonist mibolerone to cAMP- plus AG-treated cultures reduced 3 beta HSD and P450(17 alpha) mRNA to levels comparable to those observed when cells were treated with cAMP only. The glucocorticoid dexamethasone reduced both basal and cAMP- plus AG-induced increases in 3 beta HSD mRNA, but not in P450(17 alpha) mRNA. Estradiol at a concentration of 1 microM had no effect on cAMP- plus AG-induced 3 beta HSD or P450(17 alpha) mRNA levels. The role of protein synthesis in mediating the cAMP induction of 3 beta HSD, P450(17 alpha), and P450scc was investigated. The addition of cycloheximide (10 micrograms/ml) to cAMP-treated cultures for 24 h completely suppressed both constitutive and cAMP-induced 3 beta HSD mRNA levels. Cycloheximide also repressed cAMP-induced levels of P450(17 alpha) to 12% of levels observed in the absence of cycloheximide. In sharp contrast, 24-h treatment with cycloheximide did not suppress cAMP induction of P450scc mRNA, but reduced basal levels by approximately 50%. A time course of induction by cAMP (50 microM) of P450(17 alpha) and P450scc mRNA showed very similar rates of increase in P450(17 alpha) and P450scc mRNA, with the greatest increase occurring between 12 and 24 h of treatment. The results of the study demonstrate that in normal mouse Leydig cells steady state levels of mRNA for 3 beta HSD, P450(17 alpha), and P450scc are differentially regulated. cAMP is required for maximal levels of all three mRNAs. There is high constitutive expression of 3 beta HSD and P450scc mRNA, while expression of P450(17 alpha) mRNA is absolutely dependent on cAMP stimulation. Endogenously produced testosterone negatively regulates the expression of cAMP-induced P450(17 alpha) and 3 beta HSD, while the glucocorticoid dexamethasone negatively regulates 3 beta HSD and P450scc.(ABSTRACT TRUNCATED AT 400 WORDS)
在小鼠睾丸间质细胞原代培养物中,研究了δ5-3β-羟类固醇脱氢酶/δ5→δ4-异构酶(3βHSD)、17α-羟化酶/C17-20裂解酶细胞色素P450(P450(17α))和胆固醇侧链裂解细胞色素P450(P450scc)的mRNA水平调控。用8-溴-cAMP(cAMP)处理睾丸间质细胞对P450(17α) mRNA的表达至关重要,但对3βHSD则不然。用cAMP处理会导致3βHSD mRNA的基础水平降低。向经cAMP处理的培养物中添加胆固醇代谢抑制剂氨鲁米特(AG),会导致3βHSD和P450(17α) mRNA水平均升高。向经cAMP加AG处理的培养物中添加睾酮或雄激素激动剂米勃酮,会使3βHSD和P450(17α) mRNA降至仅用cAMP处理细胞时观察到的水平。糖皮质激素地塞米松降低了3βHSD mRNA的基础水平以及cAMP加AG诱导的升高,但对P450(17α) mRNA无影响。浓度为1微摩尔的雌二醇对cAMP加AG诱导的3βHSD或P450(17α) mRNA水平无影响。研究了蛋白质合成在介导cAMP对3βHSD、P450(17α)和P450scc的诱导中的作用。向经cAMP处理的培养物中添加放线菌酮(10微克/毫升)24小时,完全抑制了组成型和cAMP诱导的3βHSD mRNA水平。放线菌酮还将cAMP诱导的P450(17α)水平抑制至无放线菌酮时观察到的水平的12%。与之形成鲜明对比的是,用放线菌酮处理24小时并未抑制cAMP对P450scc mRNA的诱导,但使基础水平降低了约50%。cAMP(50微摩尔)对P450(17α)和P450scc mRNA的诱导时间进程显示,P450(17α)和P450scc mRNA的增加速率非常相似,在处理12至24小时之间增加幅度最大。研究结果表明,在正常小鼠睾丸间质细胞中,3βHSD、P450(17α)和P450scc的mRNA稳态水平受到不同调控。所有三种mRNA的最高水平都需要cAMP。3βHSD和P450scc mRNA有较高的组成型表达,而P450(17α) mRNA的表达绝对依赖于cAMP刺激。内源性产生的睾酮对cAMP诱导的P450(17α)和3βHSD的表达有负调控作用,而糖皮质激素地塞米松对3βHSD和P450scc有负调控作用。(摘要截短至400字)